Posted on 07/20/2008 11:01:24 PM PDT by HAL9000
Excerpt -
BASEL (Thomson Financial) - Roche Holdings AG said has proposed to acquire the outstanding publicly held interest in Genentech Inc. at $89.00 per share in cash, or a total payment of approximately $43.7 billion to equity holders of Genentech other than Roche. Roche acquired a majority in Genentech in 1990 and currently owns 55.9 percent of all outstanding shares.~ snip ~
(Excerpt) Read more at iii.co.uk ...
Will probably be a bump in pharm in the morning....as well as the rest of the market.
Damn! I bought DNA (Genentec) as an IPO.
No!!! For personal reasons, this stinks. Roche is taking Genentech private.
Yeah, I’m not too happy about this as well. Not sure if it’s really a done deal - my guess is Roche will have to up its offer.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.